HighTower Advisors »

Inovio Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Inovio Pharmaceuticals (INO) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $413k 30k 13.80

More positions owned by HighTower Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
NVIDIA Corporation (NVDA)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Visa Com Cl A (V)

View all positions for HighTower Advisors

Top funds holding Inovio Pharmaceuticals

Vanguard Group
Susquehanna International
BlackRock
Millennium Management
Geode Capital Management
Susquehanna Fundamental Investments
GSA Capital Partners
Qube Research & Technologies
Hrt Financial
Citadel Advisors
Morgan Stanley
Marshall Wace
Northern Trust
Bank of America Corporation
Green Alpha Advisors

View all funds holding Inovio Pharmaceuticals